• A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma
• A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL
• A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma
• A Radiation-Free Approach Based on the Whole-Body MRI Has Shown a High Level of Accuracy in the Follow-Up of Lymphoma Patients-A Single Center Retrospective Study
• Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study
• Association of both BCL2 positive and negative follicular lymphoma to clasical Hodgkin lymphoma and/or gray zone lymphoma
• Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
• Atypical lymphoplasmacytic and immunoblastic proliferation: A Systematic Review
• Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
• Baseline (18)F-FDG PET/CT may contribute to the determination of initial treatment strategy for newly diagnosed follicular lymphoma
• Case report: Suspicious laryngeal mass: a case of laryngeal lymphoma misdiagnosed as chronic inflammation
• CD6 Regulates CD4 T Follicular Helper Cell Differentiation and Humoral Immunity During Murine Coronavirus Infection
• Challenges in Diagnosing Pleural Thickening: Primary Pleural Follicular Lymphoma
• Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine
• Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes
• Cholecystocutaneous Fistula Associated with Edwardsiella tarda as a Result of Aggressive Lymphoma Development
• Chylothorax as Initial Presentation of Follicular Lymphoma: A Case Report and Literature Search
• Clinical Outcome of Patients Receiving Rituximab in Combination with Bendamustine in Indolent B-cell Lymphomas: A Single-center Institutional Study
• Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood an
• Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society of Transplantation and Cellular Therapy and the European Society of Blood and
• Clinicopathological characteristics of angioimmunoblastic T-cell lymphoma with B-cell proliferation or neoplasms
• Clinicopathological Profile of Primary Extra Nodal Lymphoma from a Tertiary Care Center in South India
• Complete hematologic response in a patient with multiple pretreated angioimmunoblastic T-cell lymphoma after belinostat therapy followed by allogeneic stem cell transplantation: A case report
• Concurrent identification of follicular lymphoma and papillary thyroid carcinoma
• Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin's lymphoma
• Correction to: Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review
• Current and future therapies for follicular lymphoma
• Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma
• Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
• Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment
• Double-hit, double-expressor follicular lymphoma with plasmacytic differentiation
• Duodenal-Type Follicular Lymphoma
• Efficacy and safety of MIL62, a novel glycoengineered type anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial
• Endoscopic resection of a primary duodenal-type follicular lymphoma
• Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma
• Follicular lymphoma of the lower female genital tract: an indolent and localized extranodal follicular lymphoma with mutation of TNFRSF14
• Frequent CDKN2B/P15 and DAPK1 methylation in duodenal follicular lymphoma is related to duodenal reactive lymphoid hyperplasia
• Gastrointestinal Follicular Lymphoma of the Cecum Treated via Endoscopic Full-Thickness Resection
• Glioblastoma concurrent with follicular lymphoma: A case report
• Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort
• Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?
• Identification of genetic subtypes in follicular lymphoma
• Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia
• Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes
• Indolent B-cell non-Hodgkin lymphomas in children: high association with inborn errors of immunity
• Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma
• Inflammatory Back Pain and Psoriasis: Expecting Spondyloarthritis, Discovering Lymphoma
• Information preferences of patients with chronic blood cancer: A qualitative investigation
• Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma
• International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline (18)F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation
• Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomas
• IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes
• Letter to the editor: A rare case of BCL-2-positive primary cutaneous follicle center lymphoma on the cheek with a high number of CD31(-) CTCs and CD31(+) CTECs in the blood
• Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial
• Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review
• Lymphoid follicular hyperplasia arising from the chest wall presenting as a substantial mass
• Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment
• Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma
• Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma
• Mechanisms of lymphoma-stromal interactions focusing on tumor-associated macrophages, fibroblastic reticular cells, and follicular dendritic cells
• Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
• Nodal T follicular helper cell lymphoma with aberrant CD20 expression and monoclonal TCR, IG rearrangements secondary to Classical Hodgkin Lymphoma: a case report
• Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?
• Non‑Hodgkin's lymphomas of the lacrimal sac: Current insights and future directions (Review)
• Obinutuzumab-Induced Inflammatory Bowel Disease-Like Pancolitis: A First Case Report
• Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study
• Pathways of patients with chronic haematological malignancies: a report from the UK’s population-based HMRN
• Pediatric-Type Follicular Lymphoma of the Conjunctiva in Two Adolescents
• Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
• Pituitary metastases: a diagnostic and therapeutic challenge
• Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
• Predicting regulatory mutations and their target genes by new computational integrative analysis: A study of follicular lymphoma
• Prolonged water-only fasting in the management of low-grade follicular lymphoma: a case series
• Promising outcomes with liso-cel in patients with R/R follicular lymphoma
• PseudoCell: Hard Negative Mining as Pseudo Labeling for Deep Learning-Based Centroblast Cell Detection
• Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma
• Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States
• Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract
• Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial
• Review of computer-assisted diagnosis model to classify follicular lymphoma histology
• Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population-based analysis
• Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes
• Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial
• Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
• Safety in Subsequent Lines of Therapy in Patients With Relapsed/Refractory Follicular Lymphoma
• Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy
• Small sized centroblasts as poor prognostic factor in follicular lymphoma - Based on artificial intelligence analysis
• Socioeconomic status, individual behaviors and risk for Lymphomas: a Mendelian randomization study
• Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
• Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine-Rituximab
• Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study
• The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas
• The Impact of Anemia on the Survival of Patients Diagnosed With Low-Grade Malignant B-cell Lymphomas
• The PI3Kdelta inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
• The Reduction of CD4(+) T Lymphocytes after the Treatment of Follicular Lymphoma with the Bendamustine Containing Regimen May Predict the Occurrence of Infection and Efficacy
• The Rules of T-cell Engagement: Current State of CAR T-cells and Bispecific Antibodies in B-cell Lymphomas
• The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy
• Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution
• Tubulointerstitial nephritis with storiform fibrosis in a patient with angioimmunoblastic T-cell lymphoma
• Vaginal involvement as a rare extranodal manifestation in advanced-stage follicular lymphoma: a case report and literature review